NEWS
December 28, 2011 | By Karen Kaplan, Los Angeles Times/For the Booster Shots blog
The flu season is still young in the U.S. and the rest of the Northern Hemisphere, but Australia wrapped up its flu season months ago, and public health officials there have some disturbing news to report: The version of so-called swine flu that is resistant to the drug Tamiflu is spreading more easily in the land Down Under. For those in need of a refresher course, swine flu refers to the H1N1 flu virus that caused a pandemic in 2009. It emerged in April in Mexico and spread swiftly around the globe, traveling to 214 countries and territories and killing more than 18,000 people, according to the World Health Organization.
HEALTH
September 19, 2011 | By Jeannine Stein, Los Angeles Times
A new villain has taken over at the multiplex. It doesn't wear a trench coat and speak with a menacing-sounding foreign accent. Nor does it have razor-sharp fangs or a home address in outer space. It can, however, lurk in the shadows, reproduce at astronomical rates — and it loves to mutate. Microscopic viruses are the biggest bad guys in Hollywood, multiplying with abandon in films such as "Contagion" and "Rise of the Planet of the Apes," as well as factoring in AMC's zombie-centric TV show "The Walking Dead.
NEWS
June 3, 2011 | By Marissa Cevallos, HealthKey / For the Booster Shots blog
The Centers for Disease Control and Prevention has unveiled its analysis of the just-ended flu season, plus its likely strategy for the upcoming flu season. In short: Expect the same plan as last year, folks. The Food and Drug Administration has recommended that the upcoming vaccine against seasonal flu protect against the same three strains as last season's formulation: H1N1 (a type of influenza A), H3N2 (another type of influenza A) and an influenza B, the CDC said in its annual flu season summary and look ahead.
CALIFORNIA | LOCAL
March 4, 2011 | By Thomas H. Maugh II, Los Angeles Times
Dr. Edwin D. Kilbourne, a virologist who figured out how to manufacture a new influenza vaccine each year and was a principal advisor to the U.S. government on flu, died Feb. 21 in Branford, Conn. He was 90. No cause of death was released. Kilbourne was involved in every aspect of preparing vaccines for the influenza season, understanding the genetics of the virus, manipulating it to create a version that would grow in eggs, and helping make the recommendation of what the vaccine formulation should be each year, Food and Drug Administration officials said on his formal retirement in 2002.
BUSINESS
January 18, 2011 | By Hugo Martín, Los Angeles Times
In another sign of an improving worldwide economy, international travel grew nearly 7% in 2010 compared with the previous year, the U.N. World Tourism Organization reported Monday. But the growth was mixed. Travel to Asia and the Middle East rebounded much faster, while the pace of growth in visitors to Europe remained sluggish and international travel to North America grew only modestly. In 2010, 935 million people traveled for business and leisure internationally, up 6.7% over 2009, but only 2% above the pre-recession levels of 2008, according to the report.
NEWS
December 29, 2010 | By Tami Dennis, Tribune Health
Flu may be making headlines in the United Kingdom, but folks in the U.S. -- almost hysterical at the specter of influenza a couple of seasons ago -- seem more concerned about anything and everything else. That's not the same thing, however, as saying there's no flu activity in this country. The UK's Health Protection Agency announced earlier this week that flu cases are on the upswing across that portion of Europe. And of course, as has been the case with the predominant H1N1 strain (formerly known as "swine flu" -- it seems so long ago now doesn't it?